Trial Profile
A Prospective Observational Safety Study on Pregnancy Outcomes in Women Immunized With Afluria, a Seasonal Influenza Vaccine, During Pregnancy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2022
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Afluria) (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Seqirus
- 07 Feb 2022 Status changed from active, no longer recruiting to completed.
- 26 Aug 2021 Planned End Date changed from 16 Dec 2021 to 30 Sep 2021.
- 26 Aug 2021 Planned primary completion date changed from 16 Dec 2021 to 30 Sep 2021.